Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer.
about
Beyond the Pap Smear: Gender-responsive HIV Care for WomenSystematic review of couple-based HIV intervention and prevention studies: advantages, gaps, and future directionsHIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and TreatmentTowards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattentionPeople who inject drugs in intimate relationships: it takes two to combat HIVWomen Who Use or Inject Drugs: An Action Agenda for Women-Specific, Multilevel, and Combination HIV Prevention and ResearchReductions in HIV/STI incidence and sharing of injection equipment among female sex workers who inject drugs: results from a randomized controlled trialInjecting and Sexual Networks and Sociodemographic Factors and Dual HIV Risk among People Who Inject Drugs: A Cross-sectional Study in Kermanshah Province, Iran.Prevalence and correlates of HIV and sexually transmitted infections among female sex workers and their non-commercial male partners in two Mexico-USA border cities.Process and product in cross-cultural treatment research: development of a culturally sensitive women-centered substance use intervention in georgiaAn exploratory study of mental health and HIV risk behavior among drug-using rural women in jail.Global Epidemiology of HIV Among Women and Girls Who Use or Inject Drugs: Current Knowledge and Limitations of Existing Data.Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions.Human immunodeficiency virus and viral hepatitis among high-risk groups: Understanding the knowledge gap in the Middle East and North Africa RegionHIV Testing, Care, and Treatment Among Women Who Use Drugs From a Global Perspective: Progress and ChallengesFactors Associated with Recent HIV Testing among Heterosexuals at High Risk for HIV Infection in New York CityUsing Peer-Referral Chains with Incentives to Promote HIV Testing and Identify Undiagnosed HIV Infections Among Crack Users in San Salvador.Sex work and HIV incidence among people who inject drugs.The relevance of social contexts and social action in reducing substance use and victimization among women participating in an HIV prevention intervention in Cape Town, South Africa.Client perspectives on design and implementation of a couples-based intervention to reduce sexual and drug risk behaviors among female sex workers and their noncommercial partners in Tijuana and Ciudad Juárez, México.Women in community corrections in New York City: HIV infection and risks.Gender differences between predictors of HIV status among PWID in Ukraine.Leveraging the U.S. Criminal Justice System to Access Women for HIV Interventions.Sex Disparities in Adverse Childhood Experiences and HIV/STIs: Mediation of Psychopathology and Sexual Behaviors.Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City.Motherhood and Risk for Human Immunodeficiency Virus/Sexually Transmitted Infections Among Female Sex Workers in the Mexico-US Border Region.Gender, Transience, Network Partnerships and Risky Sexual Practices Among Young Persons who Inject Drugs.Time Since Release from Incarceration and HIV Risk Behaviors Among Women: The Potential Protective Role of Committed Partners During Re-entry.HIV risks among injecting and non-injecting female partners of men who inject drugs in Almaty, Kazakhstan: implications for HIV prevention, research, and policy.HIV among injection drug users and their intimate partners in Almaty, Kazakhstan.The effects of opioid-agonist treatments on HIV risk and social stability: A mixed methods study of women with opioid use disorder in Ukraine.Sex-Related Disparities in Criminal Justice and HIV Treatment Outcomes: A Retrospective Cohort Study of HIV-Infected Inmates.
P2860
Q26746179-6B993086-A25E-4EFA-BC98-12A17D3E114FQ26825862-67776815-EAF2-400C-84F6-6D92E3B11E0EQ26991563-F5EBD62A-7B7E-4F91-9519-C3D91ADAB6A9Q27008531-E74F9631-2875-41FF-945C-672AA44D19A6Q27009116-08CD4B10-14E2-45C3-AFCC-0E56E1B5E779Q28083693-4B4B58D6-0E7C-4383-89EA-131A0120ABA1Q28533901-B71B9D47-F90C-460D-8329-37DCDA54C248Q33649210-04D028AB-E8C0-4C7A-A511-537694E8E575Q34051758-0A6126F1-F774-4916-9EC9-91128BA2D0B8Q34308203-78224723-EEA3-4EA3-9D80-CC04127978A0Q35213185-83148DCD-08E2-41BD-9F1B-DEABEDE55AB3Q35632859-05CE2B1C-1035-4538-950F-177E897A44FEQ35817533-20E5B263-10F9-4BF2-B54E-F9050CFCADB2Q36254138-9828B8E5-8777-4CC5-9029-AD3195961B2BQ36455197-6197E3A5-5F0E-4AE2-A624-BCF94DD924D1Q36840494-6A942450-DC09-44E1-BAA0-0A6E310DE61EQ36902008-38FF9A0E-864E-49E5-93DF-2FF4167BA4A7Q37268537-2E8935A8-2C5A-40BD-8A77-9D258F48AEFFQ37597521-D3E853CB-4242-4877-8728-88FC417A0843Q37708500-E44080ED-6363-4377-BC36-AE0E961B47EFQ37723121-8AF6DDA2-F470-4CE4-989C-7600F87BA750Q37727990-95AA80F2-5818-47C0-9621-5C19FE568A59Q38769642-AD1C345F-27F9-431F-B045-55A218D81256Q39336148-D92F721F-66F6-4DC2-B6B1-9435F3D9AD65Q40108921-2888B972-E048-4B67-8DD5-DD3A7B809FEFQ40124450-C7626262-1177-4DBC-9CB5-0F754A174F30Q40537570-E70DBD46-D56B-48DA-8A27-ED7922E02CCEQ41757119-9759F67F-101E-4E34-B7AE-C17974F8F0CFQ42227579-693EA89E-6ACB-47F4-833C-7B3A4A07A6C8Q42265544-F5983BDF-575C-469C-B482-7682F0FFC218Q44350723-53751525-2E3B-42B2-86E3-639601E935FDQ53423564-445EEF4A-79AB-47A8-9AFA-310226AB7DD5
P2860
Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dual HIV risk and vulnerabilit ...... ention strategy is the answer.
@en
type
label
Dual HIV risk and vulnerabilit ...... ention strategy is the answer.
@en
prefLabel
Dual HIV risk and vulnerabilit ...... ention strategy is the answer.
@en
P2093
P1476
Dual HIV risk and vulnerabilit ...... vention strategy is the answer
@en
P2093
Nabila El-Bassel
Stacey A Shaw
Wendee M Wechsberg
P304
P356
10.1097/COH.0B013E3283536AB2
P577
2012-07-01T00:00:00Z